Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
Lisa KobrynskiDepartment of Pediatrics, Emory University, Atlanta, GA, USAAbstract: Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in antibody production. These patients suffer from recurr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-08-01
|
| Series: | Biologics: Targets & Therapy |
| Online Access: | http://www.dovepress.com/subcutaneous-immunoglobulin-therapy-a-new-option-for-patients-with-pri-a10803 |